Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Jersey for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Jersey only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Jersey (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Edward Allegra (NPI 1588665913)

Field	Value
Entity Type	Individual
Organization	Edward Allegra
Address	282 Broad Street
City	Red Bank
State	NJ
ZIP	07701
Taxonomy	Specialist
NPI Enumerated	August 9, 2005

Payer Source	Total Paid
Medicare	$3.6M
Medicaid	$0

Key Findings

The provider's Medicare revenue is driven primarily by high-cost biologic and infusion drugs. Top drug codes include J0717 ($843.2K, 23.3% of Medicare revenue), J0129 ($636.9K, 17.6%), and J1602 ($549.4K, 15.2%), and these specific therapies are consistent with an infusion/biologics service line focused on parenteral monoclonal antibodies and disease-modifying agents rather than solely office-based procedures.

Top-line revenue concentration is substantial: the top 3 Medicare codes by revenue account for 56.2% of this provider's total Medicare revenue. This indicates heavy dependence on a small set of infusion/biologic products for the practice's Medicare business and suggests pricing, supply, and contracting for these agents will disproportionately affect revenue.

This provider is effectively a single‑payer operation at scale: Total Medicare revenue is $3.6M while Total Medicaid revenue is none (no Medicaid billing on file). The absence of Medicaid billing implies payer mix and reimbursement risk are concentrated in Medicare, which should inform network-coverage and utilization-management analyses.

For several J‑codes the provider ranks as a high-volume national participant. J0717 (210.8K claims, $4 avg paid/claim, $843.2K revenue) ranks #29 of 848 providers nationally (97th percentile; notably above typical national volume for this code), and J1602 (54.9K claims, $10 avg paid/claim, $549.4K revenue) ranks #39 of 1041 (96th percentile; notably above typical national volume), indicating nationally elevated utilization of those specific biologic products.

Other biologic codes show typical-to-unremarkable volume by national standards. J0129 ($636.9K revenue) ranks #150 of 1221 providers nationally (88th percentile; typical, unremarkable volume), and J3262 ($453.2K revenue) ranks #67 of 618 providers (89th percentile; typical, unremarkable volume), suggesting that while the practice is specialized in biologics, not all agents are outlier drivers.

The provider also reports notable chemotherapy and infusion procedure activity. 96413 ($113.2K, 3.1% of Medicare revenue) ranks #84 of 7514 providers nationally (99th percentile; extreme outlier, far above typical national volume) and 96401 ($67.1K, 1.9%) ranks #60 of 3868 providers (98th percentile; extreme outlier, far above typical national volume), which signals meaningful antineoplastic administration in addition to biologic infusions.

Visit and injection throughput is high relative to peers, consistent with frequent in-office administrations. Evaluation-and-management and injection administration codes such as 99213 ($99.9K, 2.8% of Medicare revenue) rank #2290 of 457151 providers (99th percentile; extreme outlier, far above typical national volume), 99212 ($25.1K, 0.7%) ranks #737 of 99011 (99th percentile; extreme outlier), and 96372 ($18.3K, 0.5%) ranks #131 of 58224 providers (100th percentile; extreme outlier), together indicating high outpatient visit counts and many injections performed on-site.

This provider is an established specialty practice with long tenure: NPI enumerated 2005-08-09 (~21 years ago). The combination of long-standing enrollment, concentrated Medicare revenue ($3.6M), and a code mix dominated by biologic infusions and infusion procedures suggests an entrenched infusion/biologics service model that should be prioritized for Medicare network and utilization review efforts.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

34 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	210,800	$1	$843.2K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	19,300	$30	$636.9K
J1602	Injection, golimumab, 1 mg, for intravenous use	54,940	$10	$549.4K
J3262	Injection, tocilizumab, 1 mg	90,630	$10	$453.1K
J3111	Injection, romosozumab-aqqg, 1 mg	34,020	$10	$272.2K
J0897	Injection, denosumab, 1 mg	9,600	$20	$172.8K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	4,130	$30	$128K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	980	$120	$113.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,470	$70	$99.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	1,050	$60	$67.1K

Showing 1–10 of 34

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 34 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Jersey Distribution

Edward Allegra — 12 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Jersey

Full comparison — all codes billed, vs. state median

34 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	4	40	7,600	$30	$297K
J3262	3	20	33,800	$1	$227.5K
J0717	2	60	42,300	$1	$219.5K
J1602	1	40	12,580	$10	$165.7K
J1745	26	30	3,670	$30	$131.9K
J3111	1	30	12,600	$10	$107.3K
Q5104	1	10	3,190	$30	$99.4K
J0897	40	380	3,060	$20	$87.8K
Q5121	1	10	1,820	$20	$39.9K
J7329	28	70	2,680	$10	$35.7K

Showing 1–10 of 34

Related Providers

Other providers that share a Tax Identification Number (TIN) with Edward Allegra, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Richard Haddad	NJ	Specialist	$4.3M	$0
Mia Collucci	NJ	Medical Physician Assistant	$446.8K	$0

Nearby Providers

Other providers in the same ZIP code as Edward Allegra, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Cpc Integrated Health, Inc.	NJ	Community/Behavioral Health Agency	$0	$80.7M
Hackensack Meridian Health Medical Group - Specialty Care PC	NJ	Surgical Critical Care Physician	$0	$50.1M
Hmh Hospitals Corporation	NJ	General Acute Care Hospital	$0	$26.4M
Caring With Compassion	NJ	Developmentally Disabled Services Day Training Agency	$0	$23.7M
Hackensack Meridian Health Medical Group - Primary Care PC	NJ	Family Medicine Physician	$0	$21.9M
Cpc Integrated Health, Inc.	NJ	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$16M
Hackensack Meridian Health Medical Group - Complex Care PC	NJ	Internal Medicine Physician	$0	$11.6M
Cpc Integrated Health, Inc.	NJ	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$8.8M
Meridian Medical Group - Specialty Care, PC	NJ	Specialist	$0	$8.2M
Middletown Medical, LLC	NJ	Methadone Clinic	$454.8K	$7.8M

Edward Allegra — Billing Profile & Reimbursement Data

Sign up for Edward Allegra — Billing Profile & Reimbursement Data policy alerts

Edward Allegra — Billing Profile & Reimbursement Data

Sign up for Edward Allegra — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References